Business Wire India
SIRO Clinpharm has been awarded the “Best Clinical Research Company” of the year by the CMO Asia and Stars of the Industry Group, a group dedicated to high-level knowledge exchange through leadership & networking amongst senior CMOs and brand decision makers across industry segments.
SIRO’s years of experience and incredible sustainability have been instrumental in fetching this most prestigious “Healthcare and Fitness Leadership Awards” wherein, the best industry professionals and organisations were acknowledged for their outstanding contribution in the industry. The award was conferred to SIRO, after rigorous evaluation of not only the business acumen, but also the organization’s charisma, ethics, leadership and visionary approach to diversify the business portfolio. While continuing the focus on the ‘CRO core competency’ of clinical operations and strengthening the flourishing medical writing & data services business, SIRO has consciously had a paradigm shift in business operations; there is a renewed and sustained focus on newer areas of growth like medical communication, data analytics, clinical trial supplies, transparency initiatives including redaction, TA alignment involving dedicated vaccines & devices experts, Clin Ops as an FTE-FSP business, FMCG as an independent sector. Our continuous winning streak and a positive EBIDTA year-on-year were other major contributors in getting this award home.
On behalf of the employees of SIRO, the award was received by Dr. Zubeen Dastur - Global Head of Clinical Quality Assurance, Vasudha Chandra – Sr. Manager Corporate Marketing and Medical Communications, Malti Hiranandani – Sr. Manager Strategy Alliance and Business Development and Deepa Nagpal - Executive Corporate Marketing, at the Healthcare and Fitness Leadership Awards ceremony held at Taj Land’s End in Mumbai, on 20th February, 2016.
This award follows a series of earlier wins. SIRO has also been crowned with the Frost and Sullivan Indian CRO of the year award on two consecutive occasions, previously. This industry-wide recognition is testimony of our continuing pursuit for excellence. Dr. Vatsal Shah, Chief Operating Officer at SIRO, on having won the award, said “Our unwavering mantra of making SIRO synonymous to “Quality” reflects in everything that we do to maintain the highest standards of delivery. Our quality, ethics and integrity have helped us gain year-on-year recognition, which is evident from the number of international and national accolades that are added to SIRO’s bouquet almost every year. This award comes to SIRO amidst exceptional excitement. We have truly begun this year on a high note having already bagged a number of projects at the start of the year. Receiving this award only goes to show the vigour and pride with which SIRO’s team continues to provide “simplified solutions” to the growing healthcare industry. We are thankful to CMO Asia who found us worthy of this award after a thorough scrutiny of a number of competitor CROs”.
About SIRO Clinpharm
SIRO Clinpharm is a niche drug development solutions provider to the global healthcare industry across differentiated segments such as pharma, biotech, generics, biological, consumer healthcare, nutraceuticals and medical devices. We help healthcare companies in bringing safe and effective innovations to the market with our deep domain knowledge, cutting edge technologies and dynamic and robust processes. Our subject expertise gives us an edge in clinical trial management, clinical data management, medical writing, medical communications, biostatistics and statistical programming, pharmacovigilance and clinical trial supplies management. We offer flexible business models across service verticals based on client needs. For complete information on our service offerings please visit www.siroclinpharm.com